Immune to Cancer: The CRI Blog
-
AACR19 Day 3 Update: CAR T Cells, Vaccines, and Hope Against Pancreatic Cancer
In addition to advances involving CAR T cell therapy and vaccines, a CRI-funded trial revealed the promise…
-
AACR19 Preview: CRI Scientists Showcase the Future of Immunotherapy
The 2019 AACR annual meeting kicks off March 29 in Atlanta and will feature the work of…
-
IO360 2019 Preview: Collaboration, Investment, Clinical Trials, and Combinations
The fifth annual Immuno-Oncology 360° conference will be held on February 6-8, 2019 in New York City.
-
ASH18 Preview: Blood Cancer Immunotherapy Developments at 60th American Society of Hematology Meeting
The 2018 American Society of Hematology meeting will showcase a variety of basic and clinical advances in…
-
CICON18 Day 4 Update: The Role of Bacteria; Technologies to Advance Cancer Immunotherapy
The final day of CICON18 explored two diverse areas—technology and the microbiome—that both have the…
-
CICON18 Day 3 Update: Targeting Tumor Mutations with Vaccine-Based Immunotherapies
The third day of CICON18 explored cutting-edge strategies to identify and target the mutated markers that distinguish…
-
CICON18 Preview: Translating Science into Survival
Highlights from the upcoming International Cancer Immunotherapy Conference (CICON18), including regulating T cell response, tackling the tumor…
-
Recapping the Third Annual Rational Combinations 360°
In September, experts across the immunology and immunotherapy spectrum convened in Philadelphia to discuss the latest advances…
-
Previewing the 2018 Rational Combinations 360 Conference
The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14,…